India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is Nepal famous for? Nepal is famous for a myriad of reasons, encompassing its stunning natural beauty, rich cultural heritage, and a variety of unique attractions. Here are some key aspects for which Nepal is particularly renowned: Himalayan Majesty: Mount Everest: Nepal is home to Mount Everest, the highest peak in the world. The allure of Everest draws adventurers and mountaineers from across the globe, making Nepal synonymous with high-altitude trekking and mountaineering. Trekking and Adventure: Annapurna and Langtang Regions: Apart from Everest, Nepal offers a plethora of trekking opportunities. The Annapurna Circuit and Langtang Valley are among the most popular trekking destinations, providing breathtaking landscapes and encounters with diverse cultures. Cultural Diversity: Historic Cities: Nepal boasts ancient cities like Kathmandu, Bhaktapur, and Patan, each adorned with exquisite temples, palaces, and squares. These UNESCO World Heritage Sites showcase the country'...